Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
8.02
+1.27 (18.81%)
At close: Mar 9, 2026, 4:00 PM EDT
8.05
+0.03 (0.37%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Solid Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 625 | 160 | 124 | 105 | 193 | 499 | |
| Market Cap Growth | 160.68% | 29.00% | 17.92% | -45.57% | -61.33% | 143.92% | |
| Enterprise Value | 411 | 13 | 8 | -11 | -34 | 480 | |
| Last Close Price | 8.02 | 4.00 | 6.14 | 5.38 | 26.25 | 113.70 | |
| PS Ratio | - | - | - | 12.98 | 14.17 | - | |
| PB Ratio | 2.87 | 1.16 | 0.98 | 0.50 | 0.93 | 3.78 | |
| P/TBV Ratio | 2.87 | 1.16 | 0.98 | 0.50 | 0.93 | 3.78 | |
| Debt / Equity Ratio | 0.10 | 0.18 | 0.21 | 0.14 | 0.01 | 0.04 | |
| Net Debt / Equity Ratio | -0.98 | -0.91 | -0.77 | -0.87 | -0.99 | -1.13 | |
| Net Debt / EBITDA Ratio | 1.27 | 0.98 | 0.96 | 2.01 | 2.97 | 1.81 | |
| Net Debt / FCF Ratio | 1.61 | 1.24 | 1.02 | 1.83 | 2.60 | 2.60 | |
| Asset Turnover | - | - | - | 0.03 | 0.07 | - | |
| Quick Ratio | 6.50 | 4.92 | 8.52 | 9.49 | 8.81 | 6.32 | |
| Current Ratio | 6.74 | 5.20 | 8.94 | 9.76 | 9.43 | 6.49 | |
| Return on Equity (ROE) | -86.83% | -94.56% | -56.79% | -40.96% | -42.43% | -83.24% | |
| Return on Assets (ROA) | -43.67% | -45.86% | -30.67% | -23.95% | -22.38% | -39.35% | |
| Return on Capital Employed (ROCE) | -71.40% | -81.90% | -69.30% | -39.70% | -34.60% | -58.90% | |
| Earnings Yield | -26.75% | -78.02% | -77.50% | -81.84% | -37.40% | -17.69% | |
| FCF Yield | -21.31% | -62.99% | -77.24% | -96.13% | -40.95% | -11.52% | |
| Buyback Yield / Dilution | -111.62% | -105.27% | -133.60% | -19.59% | -105.58% | -28.91% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.